Prevent Washington

Learning to live with COVID-19 It’s possible to achieve population or herd immunity from COVID-19 if we can drive the post-vaccination boosting immunity to levels that would prevent spread.

“We knew, given the political and social climate, that even once we had a vaccine our work was still cut out for us in terms of acceptability and uptake, so having the trials represent the people most impacted was really critical.”

Dr. Michele Andrasik discussed the importance of Black, Indigenous, and People Of Color (BIPOC) community engagement in vaccine trials. Read more from Cambridge Healthtech Institute: https://bit.ly/3HwBoZB

F.D.A. Clears First Coronavirus Vaccine for 5- to 11-Year-Olds The shot could bring relief to parents anxious about their children getting sick, though some experts worry that those most at risk may slip through the cracks.

Community engagement ensures equitable inclusion in vaccine trials Researchers from the COVID-19 Prevention Network have demonstrated that through robust community engagement, equitable inclusion in vaccine clinical trials can make a powerful impact in the health of underrepresented communities.

Using AI to identify potential COVID-19, cancer therapies Fred Hutch researchers are using machine learning and other AI tools to screen, identify and validate drug compounds that inhibit COVID-19's deadly cytokine storms, at least in mice and cells. Their AI drug discovery platform holds promise for identifying potential cancer therapies, too.

Ongoing trials test COVID-19 drugs for earlier, easier treatment At the COVID-19 Clinical Research Center on the Fred Hutch campus, people who recently received a positive test for SARS-CoV-2 are enrolled in trials of injectable antibodies and experimental antiviral drugs to see if these interventions may reduce the severity of symptoms and keep at risk patients....